Ovoca Presents at BIO-Europe Spring® 2019, Vienna
Ovoca is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany), an experienced biopharmaceutical drug development consultancy firm, to provide regulatory affairs services.
Ovoca is pleased to announce that on 25th of September 2018 the notary public notified the Company that its subsidiary, Silver Star Ltd., has been formally registered on the Russian Unified State Register of Legal Entities as the owner of ...
|March 24, 2020||Acquisition of Remaining Minority Shareholding in IVIX LLC|
|September 16, 2019||Interim Results|
|September 12, 2019||Filing of Marketing Authorisation Application with Russian Ministry of Health for BP-101|
|June 28, 2019||Annual Report 2018|
|May 25, 2018||Annual Report 2017|
|June 30, 2017||Annual Report 2016|
|November 20, 2019||Ovoca Bio plc BP-101 Presentation|
|March 29, 2019||Ovoca Bio plc | Libicore Presentation|
|July 27, 2018||Ovoca Bio plc | Libicore Presentation|